On June 5, 2025, Sana Biotechnology, Inc. held its annual meeting where stockholders elected Class I directors and ratified Ernst & Young LLP as auditors for 2025. The election included nominees Steven D. Harr, Robert L. Rosiello, Michelle Seitz, and Patrick Y. Yang.